Spectral Medical, Inc. (EDT.TO)
1.11
-0.07
(-5.93%)
CAD |
TSX |
Oct 05, 15:59
Spectral Medical Enterprise Value : 370.32M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 370.32M |
| October 01, 2026 | 370.32M |
| September 30, 2026 | 358.58M |
| September 29, 2026 | 367.39M |
| September 28, 2026 | 367.39M |
| September 25, 2026 | 367.39M |
| September 24, 2026 | 361.51M |
| September 23, 2026 | 349.77M |
| September 22, 2026 | 355.64M |
| September 21, 2026 | 343.90M |
| September 18, 2026 | 370.32M |
| September 17, 2026 | 387.93M |
| September 16, 2026 | 393.80M |
| September 15, 2026 | 396.74M |
| September 14, 2026 | 402.61M |
| September 11, 2026 | 393.80M |
| September 10, 2026 | 393.80M |
| September 09, 2026 | 393.80M |
| September 08, 2026 | 393.80M |
| September 04, 2026 | 393.80M |
| September 03, 2026 | 402.61M |
| September 02, 2026 | 396.74M |
| September 01, 2026 | 405.55M |
| August 31, 2026 | 408.48M |
| August 28, 2026 | 414.35M |
| Date | Value |
|---|---|
| August 27, 2026 | 414.35M |
| August 26, 2026 | 414.35M |
| August 25, 2026 | 420.22M |
| August 24, 2026 | 420.22M |
| August 21, 2026 | 417.29M |
| August 20, 2026 | 414.35M |
| August 19, 2026 | 408.48M |
| August 18, 2026 | 437.84M |
| August 17, 2026 | 434.90M |
| August 14, 2026 | 429.03M |
| August 13, 2026 | 437.84M |
| August 12, 2026 | 431.97M |
| August 11, 2026 | 431.97M |
| August 10, 2026 | 431.97M |
| August 07, 2026 | 437.84M |
| August 06, 2026 | 434.90M |
| August 05, 2026 | 434.90M |
| August 04, 2026 | 437.84M |
| July 31, 2026 | 431.97M |
| July 30, 2026 | 434.90M |
| July 29, 2026 | 431.97M |
| July 28, 2026 | 426.10M |
| July 27, 2026 | 429.03M |
| July 24, 2026 | 420.22M |
| July 23, 2026 | 429.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Resverlogix Corp. | 141.14M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 4.574M |
| Restart Life Sciences Corp. | 4.263M |
| Covalon Technologies Ltd. | 92.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.331M |
| Revenue (Quarterly) | 0.621M |
| Total Expenses (Quarterly) | 0.29M |
| EPS Diluted (Quarterly) | 0.0011 |
| Gross Profit Margin (Quarterly) | -186.3% |
| Profit Margin (Quarterly) | 53.30% |
| Earnings Yield | -11.19% |
| Normalized Earnings Yield | -7.000 |